(Q46407013)

21 December 2017

title

Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors (English)

1 reference

21 December 2017

author name string

C M Maillard

1

1 reference

21 December 2017

C Bouquet

2

1 reference

21 December 2017

M M Petitjean

3

1 reference

21 December 2017

M Mestdagt

4

1 reference

21 December 2017

E Frau

5

1 reference

21 December 2017

M Jost

6

1 reference

21 December 2017

A M Masset

7

1 reference

21 December 2017

P H Opolon

8

1 reference

21 December 2017

F Beermann

9

1 reference

21 December 2017

M M Abitbol

10

1 reference

21 December 2017

J M Foidart

11

1 reference

21 December 2017

M J Perricaudet

12

1 reference

21 December 2017

A C Noël

13

1 reference

21 December 2017

language of work or name

English

0 references

publication date

27 August 2008

1 reference

21 December 2017

published in

Carcinogenesis

1 reference

21 December 2017

volume

29

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

2236-2242

1 reference

21 December 2017

Role of plasminogen activator-plasmin system in tumor angiogenesis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Evolving role of uPA/uPAR system in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Cancer invasion and metastasis: changing views.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Functional overlap between two classes of matrix-degrading proteases in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Regulation of proliferation-survival decisions is controlled by FGF1 secretion in retinal pigmented epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Sustained low levels of fibroblast growth factor-1 promote persistent microvascular network formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

LRP: a multifunctional scavenger and signaling receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Systemic administration of a recombinant adenovirus encoding a HSA-Angiostatin kringle 1-3 conjugate inhibits MDA-MB-231 tumor growth and metastasis in a transgenic model of spontaneous eye cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Site-directed targeting of plasminogen activator inhibitor-1 as an example for a novel approach in rational drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Characterization of a small molecule PAI-1 inhibitor, ZK4044.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN204

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN204

1 reference

21 December 2017

PubMed ID

18753414

1 reference

21 December 2017